MacroGenics
MGNX
#9382
Rank
NZ$0.15 B
Marketcap
NZ$2.41
Share price
-0.71%
Change (1 day)
-59.09%
Change (1 year)

Market capitalization of MacroGenics (MGNX)

Market cap: NZ$0.15 Billion

As of December 2025 MacroGenics has a market cap of NZ$0.15 Billion. This makes MacroGenics the world's 9382th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MacroGenics from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.15 B-57.57%
2024NZ$0.35 B-61.9%
2023NZ$0.94 B45.23%
2022NZ$0.64 B-54.9%
2021NZ$1.44 B-19.16%
2020NZ$1.78 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of MacroGenics was reported to be:

NZ$0.15 Billion
by Nasdaq info icon info icon
NZ$0.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
NZ$2.03 B 1,232.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.09 B 165,857.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$431.40 B 282,784.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$257.25 B 168,587.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$294.62 B 193,094.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.586 T 1,039,983.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$183.72 B 120,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA